Amylyx Pharmaceuticals Etf Price Prediction
| AMLX Etf | USD 4.05 0.09 2.27% |
Oversold Vs Overbought
44
Oversold | Overbought |
EPS Estimate Next Quarter (0.56) | EPS Estimate Current Year (4.29) | EPS Estimate Next Year (2.13) | Wall Street Target Price 8 | EPS Estimate Current Quarter (0.71) |
Using Amylyx Pharmaceuticals hype-based prediction, you can estimate the value of Amylyx Pharmaceuticals from the perspective of Amylyx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Amylyx Pharmaceuticals to buy its etf at a price that has no basis in reality. In that case, they are not buying Amylyx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amylyx Pharmaceuticals after-hype prediction price | USD 4.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Amylyx |
Amylyx Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Amylyx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amylyx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Amylyx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amylyx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Amylyx Pharmaceuticals' etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amylyx Pharmaceuticals' historical news coverage. Amylyx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.20 and 9.76, respectively. We have considered Amylyx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amylyx Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of Amylyx Pharmaceuticals is based on 3 months time horizon.
Amylyx Pharmaceuticals Etf Price Prediction Analysis
Have you ever been surprised when a price of a ETF such as Amylyx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amylyx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amylyx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.62 | 5.67 | 0.04 | 0.16 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.05 | 4.09 | 0.99 |
|
Amylyx Pharmaceuticals Hype Timeline
Amylyx Pharmaceuticals is presently traded for 4.05. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of -0.16. Amylyx is expected to increase in value after the next headline, with the price projected to jump to 4.09 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.99%, whereas the daily expected return is presently at 0.62%. The volatility of related hype on Amylyx Pharmaceuticals is about 2256.72%, with the expected price after the next announcement by competition of 3.89. The company reported the previous year's revenue of 380.79 M. Net Income was 49.27 M with loss before overhead, payroll, taxes, and interest of (74.21 M). Given the investment horizon of 90 days the next expected press release will be in about 11 days. Check out Amylyx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Amylyx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Amylyx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Amylyx Pharmaceuticals' future price movements. Getting to know how Amylyx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amylyx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TERN | Terns Pharmaceuticals | (0.05) | 10 per month | 0.00 | (0.19) | 5.17 | (6.80) | 26.61 | |
| ABOS | Acumen Pharmaceuticals | (0.52) | 6 per month | 0.00 | (0.1) | 6.70 | (6.78) | 28.07 | |
| INZY | Inozyme Pharma | (0.26) | 7 per month | 0.00 | (0.24) | 5.84 | (7.92) | 16.32 | |
| XFOR | X4 Pharmaceuticals | (0.22) | 10 per month | 10.68 | 0.04 | 13.85 | (13.51) | 67.48 | |
| DAWN | Day One Biopharmaceuticals | (0.59) | 10 per month | 0.00 | (0.08) | 3.21 | (3.69) | 11.05 | |
| MREO | Mereo BioPharma Group | (0.23) | 6 per month | 0.00 | (0.11) | 4.71 | (6.31) | 16.40 | |
| PDSB | PDS Biotechnology Corp | 0.14 | 9 per month | 0.00 | (0.17) | 8.37 | (8.65) | 31.83 | |
| HOOK | Hookipa Pharma | (0.28) | 7 per month | 0.00 | (0.31) | 6.85 | (6.67) | 22.36 |
Amylyx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Amylyx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amylyx using various technical indicators. When you analyze Amylyx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amylyx Pharmaceuticals Predictive Indicators
The successful prediction of Amylyx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amylyx Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amylyx Pharmaceuticals based on analysis of Amylyx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amylyx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amylyx Pharmaceuticals's related companies.
Story Coverage note for Amylyx Pharmaceuticals
The number of cover stories for Amylyx Pharmaceuticals depends on current market conditions and Amylyx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amylyx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amylyx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amylyx Pharmaceuticals Short Properties
Amylyx Pharmaceuticals' future price predictability will typically decrease when Amylyx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amylyx Pharmaceuticals often depends not only on the future outlook of the potential Amylyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amylyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70 M | |
| Cash And Short Term Investments | 371.4 M |
Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.